• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
53.89
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Kotak Mahindra Bank receives RBI approval to acquire up to 9.99% stake in AU Small Finance Bank
May 07,2026
AU Small Finance Bank (AU SFB) has received RBI's letter dated 06 May 2026 according its approval to Kotak Mahindra Bank (KMBL) (along with its subsidiaries, the funds/schemes managed by KMBL's subsidiaries, collective referred as Kotak Mahindra Group) to acquire ‘aggregate holding' of up to 9.99% of the paid-up share capital or voting rights in AU SFB.